Results 71 to 80 of about 37,865 (174)

SARS-CoV-2 em superfícies: persistência e medidas preventivas – uma revisão sistemática

Journal Health NPEPS, 2020
Objetivo: verificar a persistência do SARS-CoV-2 nas diferentes superfícies e medidas preventivas contra a transmissão do vírus. Método: revisão sistemática norteada pelo método PRISMA.
Lara Azevedo Teixeira, Wellington Roberto Gomes de Carvalho   +1 more
doaj   +1 more source

Nano‐ and Micro‐Sized Solid Materials Used as Antiviral Agents

Advanced Functional Materials, Volume 36, Issue 26, 30 March 2026.
Due to the rise of viral infections in humans and possible viral outbreaks, the use of nano‐ or micro‐sized materials as antiviral agents is rapidly increasing. This review explores their antiviral properties against RNA and DNA viruses, either as a prevention or a treatment tool, by delving into their mechanisms of action and how to properly assess ...
Orfeas‐Evangelos Plastiras, Imelda Raczkiewicz, Peggy Bouquet, Jean‐Philippe Dacquin, Jeremy Dhainaut, Anne Goffard, Christophe Volkringer   +6 more
wiley   +1 more source

A Lung‐Immune Dual‐Humanized Mouse Using Cryopreserved Tissue Enables Infection and Immune Profiling of Human Common Cold Coronaviruses

Advanced Science, Volume 13, Issue 16, 18 March 2026.
Cryopreserved lung‐humanized mice overcome the dependency to fresh tissues and permit head‐to‐head profiling of all four human common cold coronaviruses versus SARS‐CoV‐2 infection; the model validates Paxlovid efficacy against HKU1 and, when coupled with human immune‐system engraftment, enables interrogation of lung‐resident human immunity and HKU1 ...
Chunyu Cheng, Jing Sun, Chun Lu, Qian Yu, Yiyun He, Bingqing Wu, Deshan Ren, Shuai Ding, Jincun Zhao, Yan Li   +9 more
wiley   +1 more source

Viral Immunity in Immunoglobulin Products: Global Immunity Debt and Autoimmunity in the Postpandemic Era

European Journal of Immunology, Volume 56, Issue 3, March 2026.
Immunoglobulin products derived from pooled global plasma reflect population‐level antiviral immunity. Analysis of batches from 2017 to 2023 reveals pandemic‐driven shifts in viral antibody profiles and a concurrent rise in autoantibodies, notably against TRIM21/Ro52, highlighting links between SARS‐CoV‐2, immunity debt, and autoimmunity.
Hannes Lindahl, Katy Shaw‐Saliba, H. Benjamin Larman, C. I. Edvard Smith, Peter Bergman   +4 more
wiley   +1 more source

Structural Basis of MERS‐CoV Receptor Interactions and Antibody Neutralisations

Reviews in Medical Virology, Volume 36, Issue 2, March 2026.
ABSTRACT Increasing outbreaks of coronaviruses underscore the importance of antivirals and vaccines that can combat a wide range of coronaviruses. Neutralising antibodies (nAbs), along with vaccines and small‐molecule drugs, are among the most promising treatments and prevention options against coronaviruses.
Edem Gavor, Yeu Khai Choong, Sunil Singh, Hariharan Sivaraman, Er Shi Yin, J. Sivaraman   +5 more
wiley   +1 more source

Cross‐Reactive IgG Antibody Responses to SARS‐CoV‐2 in Older Adults Following Seasonal Coronavirus Infection in Jiangsu, China (2015–2017)

Influenza and Other Respiratory Viruses, Volume 20, Issue 3, March 2026.
ABSTRACT The extent of cross‐reactive antibodies to SARS‐CoV‐2 elicited by seasonal human coronaviruses (HCoVs) remains unclear. We analyzed longitudinal preinfection and postinfection IgG responses in 62 older adults with PCR‐confirmed HCoV infections from sera collected prior to the emergence of SARS‐CoV‐2.
Cheng Xiao, Nancy H. L. Leung, Shiman Ling, Xia Lin, Yuyun Chen, Yanmin Xie, Malik Peiris, Mark Zanin, Benjamin Cowling, Sook‐San Wong   +9 more
wiley   +1 more source

Strategic Preparedness of Broad‐Spectrum Antivirals for Rapid Response Towards Next Pandemics

Small Science, Volume 6, Issue 1, January 2026.
Nanoengineered broad‐spectrum antivirals (BSAs) represent a transformative approach to pandemic preparedness. Unlike virus‐specific drugs requiring separate development, BSAs act across multiple viral families through nanoengineering strategies that enhance solubility, bioavailability, and host‐targeted activity.
Sanoj Rejinold N, Geun‐woo Jin, Jin‐Ho Choy   +2 more
wiley   +1 more source

Circulation of Alphacoronavirus, Betacoronavirus and Paramyxovirus in Hipposideros bat species in Zimbabwe

Infection, Genetics and Evolution, 2018
(Uploaded by Plazi for the Bat Literature Project) Bats carry a great diversity of zoonotic viruses with a high-impact on human health and livestock. Since the emergence of new coronaviruses and paramyxoviruses in humans (e.g. Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Nipah virus), numerous studies clearly established that bats can ...
Bourgarel, Mathieu, Pfukenyi, Davies, Boué, Vanina, Talignani, Loïc, Chiweshe, Ngoni, Diop, Fode, Caron, Alexandre, Matope, Gift, Missé, Dorothée, Liegeois, Florian   +9 more
openaire   +6 more sources

From Widespread Use to Loss of Effectiveness: The Consequences of Inappropriate Azithromycin Prescriptions During the COVID‐19 Pandemic—A Systematic Review and Meta‐Analysis

International Journal of Microbiology, Volume 2026, Issue 1, 2026.
Objectives We are aimed at evaluating whether the widespread use of azithromycin during the COVID‐19 pandemic led to a significant increase in bacterial resistance compared with the prepandemic period and estimating the magnitude of this effect through a systematic review and meta‐analysis.
Beatriz Birelli do Nascimento, Bianca Gianola Belline Silva, Leandro Aparecido de Souza, Jessica Cristina Bilizario Nogueirol Andrade, Fernando de Sá Del Fiol, Hassan Latrache   +5 more
wiley   +1 more source

Attenuated Infectious Bronchitis Virus (IBV) Vaccination Induces Protective Humoral and Cellular Immunity Against SARS‐CoV‐2 in Mammals

Journal of Immunology Research, Volume 2026, Issue 1, 2026.
Occupational exposure to infectious bronchitis virus (IBV) has been associated with cross‐reactivity to other coronaviruses such as SARS‐CoV‐2. In this study, we investigated the immune response of IBV using reconstituted samples of the commercial H120 Mass‐I vaccine (Zoetis) against SARS‐CoV‐2 infection.
Ney de Carvalho Almeida, Mauricio Fraga van Tilburg, Bruno Bezerra da Silva, João Xavier da Silva Neto, Luiz Francisco Wemmenson Gonçalves Moura, Natália do Vale Canabrava, Diane Isabelle Magno Cavalcante, Deysi Viviana Tenazoa Wong, Roberto César Pereira Lima Júnior, Daniel Pascoalino Pinheiro, Dayane Alves Costa, Danúbio Andrade Bezerra Farias, Pablo Abreu de Morais, Valder Nogueira Freire, Valdir Ferreira de Paula Junior, Francisco Franciné Maia Júnior, Diego Veras Wilke, Gilvan Pessoa Furtado, Eridan Orlando Pereira Tramontina Florean, Maria Izabel Florindo Guedes, Poorani Gurumallesh   +20 more
wiley   +1 more source